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INTRODUCTION
                   Analytical chemistry is the study of the chemical composition of 
natural and artificial materials.Unlike other major sub disciplines of chemistry 
such as inorganic chemistry and organic chemistry, analytical chemistry is not 
restricted to any particular type of chemical compound or reaction.Properties 
studied in analytical chemistry include geometric features such as molecular 
morphologies distributions of species, as well as features such as composition 
and species identity. The contributions made by analytical chemists have played 
critical roles in the sciences ranging from the development  of  concepts and 
theories (pure science) to a variety of practical applications, such as biomedical 
applications, environmental monitoring, quality control of industrial 
manufacturing and forensic science
                    .
                        Modern analytical chemistry is dominated by instrumental 
analysis. Many analytical chemists focus on a single type of 
instrument.Academics tend to either focus on new applications and discoveries 
or on new methods of analysis.
                                An effort to develop a new method might involve the use of 
a tunable laser to increase the specificity and sensitivity of a spectrometric 
method. Many methods, once developed,are kept purposely static so that data 
can be compared over long periods of time. 
                      Traditionally, analytical chemistry has been split into two main 
types
 [1] Qualitative
           Qualitative inorganic analysis seeks to establish the presence of a given 
element or inorganic compound in a sample. 
          Qualitative organic analysis seeks to establish the presence of a given 
functional group or organic compound in a sample.
 
  [2] Quantitative
          Quantitative analysis seeks to establish the amount of a given element or 
compound in a sample. 
                          Most modern analytical chemistry is categorized by two 
different approaches such as analytical targets or analytical methods .
 
 By Analytical Targets
       Bioanalytical chemistry 
       Material analysis 
       Chemical analysis 
       Environmental analysis 
       Forensics 
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 By Analytical Methods
     
  Spectroscopy 
       Mass Spectrometry 
       Spectrophotometry and Colorimetry 
     
       Chromatography and Electrophoresis 
       Crystallography 
       
       Microscopy 
       Electrochemistry 
 Traditional analytical techniques
      
                     Although modern analytical chemistry is dominated by 
sophisticated instrumentation, the roots of analytical chemistry and some of the 
principles used in modern instruments are from traditional techniques many of 
which are still used today. These techniques also tend to form the backbone of 
most undergraduate analytical chemistry educational labs.
Titration      
                    Titration involves the addition of a reactant to a solution being 
analyzed until some equivalence point is reached. Often the amount of material 
in the solution being analyzed may be determined. Most familiar to those who 
have taken college chemistry is the acid-base titration involving a color 
changing indicator. There are many other types of titrations, for example 
potentiometric titrations. These titrations may use different types of indicators 
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to 
reach some equivalence point.
Gravimetry.
                  Gravimetric analysis involves determining the amount of material 
present by weighing the sample before and/or after some transformation. A 
common example used in undergraduate education is the determination of the 
amount of water in a hydrate by heating the sample to remove the water such 
that the difference in weight is due to the water lost.
Inorganic qualitative analysis
                  Inorganic qualitative analysis generally refers to a systematic scheme 
to confirm the presence of certain, usually aqueous, ions or elements by 
performing a series of reactions that eliminate ranges of possibilities and then 
confirms suspected ions with a confirming test. Sometimes small carbon 
containing ions are included in such schemes. With modern instrumentation 
these tests are rarely used but can be useful for educational purposes and in field 
work or other situations where access to state-of-the-art instruments are not 
available or expedient.
 Instrumental Analysis       
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Block diagram of an analytical instrument showing the stimulus and 
measurement of response.
Spectroscopy1,2,3
         
           Spectroscopy measures the interaction of the molecules with 
electromagnetic radiation. Spectroscopy consists of many different applications 
such as atomic absorption spectroscopy, atomic emission spectroscopy, 
ultraviolet-visible spectroscopy, x-ray fluorescence spectroscopy, 
infrared spectroscopy, Raman spectroscopy,
 nuclear magnetic resonance spectroscopy, photoemission spectroscopy, 
Mössbauer spectroscopy and so on.
Mass Spectrometry
           
       Mass spectrometry measures mass-to-charge ratio of molecules using 
electric and magnetic fields. There are several ionization methods: electron 
impact, chemical ionization, electrospray, fast atom bombardment, matrix 
assisted laser desorption ionization, and others. Also, mass spectrometry is 
categorized by approaches of mass analyzers: 
magnetic-sector,quadrupole mass analyzer, quadrupole ion trap, Time-of-flight, 
Fourier transform ion cyclotron resonance, and so on.
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Crystallography
                Crystallography is a technique that characterizes the chemical 
structure of materials at the atomic level by analyzing the diffraction patterns of 
usually x-rays that have been deflected by atoms in the material. From the raw 
data the relative placement of atoms in space may be determined.
Electrochemical Analysis
                Electroanalytical methods measure the potential (volts) and/or current 
(amps) in an electrochemical cell containing the analyte.[5]  [6]   These methods 
can be categorized according to which aspects of the cell are controlled and 
which are measured. The three main categories are potentiometry (the 
difference in electrode potentials is measured), coulometry (the cell's current is 
measured over time), and voltammetry (the cell's current is measured while 
actively altering the cell's potential).
Thermal Analysis
               Calorimetry and thermogravimetric analysis measure the interaction of 
a material and heat.
Separation
              Separation processes are used to decrease the complexity of material 
mixtures. Chromatography and electrophoresis are representative of this field.
Hybrid Techniques
             Combinations of the above techniques produce "hybrid" or 
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"hyphenated" techniques. Several examples are in popular use today and new 
hybrid techniques are under development. For example,
 Gas chromatography-mass spectrometry, LC-MS, GC-IR, LC-NMR, LC-IR, 
CE-MS, and so on.
              
                  Hyphenated separation techniques refers to a combination of two (or 
more) techniques to detect and separate chemicals from solutions. Most often 
the other technique is some form of chromatography. Hyphenated techniques 
are widely used in chemistry and biochemistry. A slash is sometimes used 
instead of hyphen, especially if the name of one of the methods contains a 
hyphen itself.
Examples of hyphenated techniques:
LC-MS (or HPLC-MS) 
HPLC/ESI-MS 
LC-DAD 
CE-MS 
CE-UV 
GC-MS 
LC-IR 
Microscopy
              The visualization of single molecules, single cells, biological tissues 
and nano- micro materials is very important and attractive approach in 
analytical science. Also, hybridization with other traditional analytical tools is 
revolutionizing analytical science. Microscopy can be categorized into three 
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different fields: optical microscopy, electron microscopy, and 
scanning probe microscopy. Recently, this field is rapidly progressing because 
of the rapid development of computer and camera industries.
Lab-on-a-chip
               Devices that integrate (multiple) laboratory functions on a single chip 
of only millimeters to a few square centimeters in size and that are capable of 
handling extremely small fluid volumes down to less than pico liters.
Methods and data analysis 
Standard Curve
               A standard method for analysis of concentration involves the creation 
of a calibration curve. This allows for determination of the amount of a 
chemical in a material by comparing the results of unknown sample to those of 
a series known standards.If the concentration of element or compound in a 
sample is too high for the detection range of the technique, it can simply be 
diluted in a pure solvent. If the amount in the sample is below an instrument's 
range of measurement, the method of addition can be used. In this method a 
known quantity of the element or compound under study is added, and the 
difference between the concentration added, and the concentration observed is 
the amount actually in the sample.
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Internal Standards
              Sometimes an internal standard is added at a known concentration 
directly to an analytical sample to aid in quantitation. The amount of analyte 
present is then determined relative to the internal standard as a calibrant.
              Analytical chemistry research is largely driven by performance 
(sensitivity, selectivity, robustness, linear range, accuracy, precision, and 
speed), and cost (purchase, operation, training, time, and space). Among the 
main branches of contemporary analytical atomic spectrometry, the most 
widespread and universal are optical and mass spectrometry 
(see Prospects in Analytical Atomic Spectrometry). In the direct elemental 
analysis of solid samples, the new leaders are laser-induced breakdown and 
laser ablation mass spectrometry, and the related techniques with transfer of the 
laser ablation products into inductively coupled plasma. 
                  Advances in design of diode lasers and optical parametric oscillators 
promote developments in fluorescence and ionization spectrometry and also in 
absorption techniques where uses of optical cavities for increased effective 
absorption pathlength are expected to expand. Steady progress and growth in 
applications of plasma- and laser-based methods are noticeable. An interest 
towards the absolute (standardless) analysis has revived, particularly in the 
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emission spectrometry.
                    A lot of effort is put in shrinking the analysis techniques to chip 
size. Although there are few examples of such systems competitive with 
traditional analysis techniques, potential advantages include size/portability, 
speed, and cost. (micro Total Analysis System (µTAS) or Lab-on-a-chip). 
Microscale chemistry reduces the amounts of chemicals used.
Much effort is also put into analyzing biological systems. Examples of rapidly 
expanding fields in this area are:
1)Genomics - DNA sequencing and its related research. Genetic fingerprinting 
and DNA microarray are very popular tools and research fields. 
2)Proteomics - the analysis of protein concentrations and modifications, 
especially in response to various stressors, at various developmental stages, or 
in various parts of the body. 
3)Metabolomics - similar to proteomics, but dealing with metabolites.
4)Transcriptomics- mRNA and its associated field 
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5)Lipidomics - lipids and its associated field 
6)Peptidomics - peptides and its associated field 
7)Metalomics - similar to proteomics and metabolomics, but dealing with metal 
concentrations and especially with their binding to proteins and other 
molecules. 
                         Analytical chemistry has played critical roles in the 
understanding of basic science to a variety of practical applications, such as 
biomedical applications, environmental monitoring, quality control of industrial 
manufacturing, forensic science and so on.
The recent developments of computer automation and information technologies 
have innervated analytical chemistry to initiate a number of new biological 
fields.
                        For example, automated DNA sequencing machines were the 
basis to complete human genome projects leading to the birth of genomics. 
Protein identification and peptide sequencing by mass spectrometry opened a 
new field of proteomics. Furthermore, a number of ~omics based on analytical 
chemistry have become important areas in modern biology.
                        Also, analytical chemistry has been an indispensable area in the 
development of nanotechnology. Surface characterization instruments, 
electron microscopes and scanning probe microscopes enables scientists to 
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visualize atomic structures with chemical characterizations.
                        Analytical chemistry is pursuing the development of practical 
applications and commercial instruments rather than elucidating scientific 
fundamentals. This may be an arguable difference from overlapping science 
areas such as physical chemistry and biophysics, although there isn't any 
distinct 
boundaries among disciplines in contemporary science and technology. 
                   However, this aspect may attract many engineers' interest; thus, it 
is not difficult to see papers from engineering departments in analytical 
chemistry journals.
              Among active contemporary analytical chemistry research fields, micro 
total analysis system is considered as a great promise of revolutionary 
technology. In this approach, integrated and miniaturized analytical systems are 
being developed to control and analyze single cells and single molecules. This 
cutting-edge technology has a promising potential of leading a new revolution 
in science as integrated circuits did in computer developments
18
SPECTROSCOPY
It is the measurement and interpretation of electromagnetic radiations 
absorbed or emitted when the molecules or atoms or ions of the sample undergo 
transition from one energy state (Ground state) to another (excited state).
It is of two types,
Absorption Spectroscopy:
Where absorption of electro magnetic radiation (EMR) takes place.
(eg.) Colorimetry, UV spectroscopy, IR spectroscopy, etc. 
Emission Spectroscopy:  
Where emission of radiation is being studied.
(eg.) Fluorimetry, Flame Photometry.
Quantitative Spectrophotometric Assay:
The assay of an absorbing substance may be quickly carried out by 
preparing a solution in a transparent solvent and measuring its absorbance at a 
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suitable wavelength.
The wavelength normally selected is a wavelength of maximum 
absorption (λmax). 
UV – SPECTROSCOPY 4,5
                      It involves the measurement of amount of ultra-violet radiation 
absorbed by a substance in the solution. The wavelength between 190 – 390 nm 
(practically 200 – 400 nm) is considered to be UV radiations/ region. Coloured 
compounds absorb in visible range i.e. 400-800 nm. 
The assay of an absorbing substance can be carried out by using
Standard absorptivity Value.
Use of calibration graph.
Single point standardisation.
Standard absorptivity value:
                  This procedure is adopted by official compendia for the stable 
substance that have reasonably broad absorption bands and which are 
practically unaffected by variation of instrumental parameters. The use of 
standard A (1%, 1cm) value avoids the need to prepare a standard solution of 
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the reference substance in order to determine its absorptivity.
Use of calibration graph:
                 In this procedure, the absorbance of a number (typically 4-6) of 
standard solution of the reference substance at concentrations encompassing 
sample concentration are measured and a calibration graph is constructed. The 
concentration of the analyte in the sample solution is read from the graph as a 
concentration corresponding to absorbance of the solution .
Single point standardization
                 This procedure involves the measurement of the absorbance of a 
sample solution and of a standard solution of the reference substance. The 
standard and sample solution are prepared in a similar manner, ideally the 
concentration of standard solution should be close to that sample solution. The 
concentration of the substance in the sample is calculated using.
Ctest = A xCtest  standard
A standard
Where C test and C standard are the concentrations in the sample and standard 
solutions and A test and A standard are the absorbances of sample and standard 
solutions respectively. Important characteristics of spectrophotometric methods 
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include.
High sensitivities
Moderate to high selectivity
Good accuracy
Wide applicability to both organic and inorganic systems.
Easy and convenience of data acquisition.
                      
                     The use of UV and visible spectroscopy for quantitative analysis 
employs the method of comparing the absorbance of standards and samples at a 
selected wavelength. The analysis of mixtures of two or more components is 
facilitated by activity of absorbance. Other applications include measurement of 
absorption of complexes to establish their composition. All chromogenic 
compounds are not suitable for quantitative measurements, i.e. the choice of the 
system and procedure depends largely on the chemistry of the species to be 
determined.
ASSAY OF SUBSTANCES IN MULTI COMPONENT SAMPLES
They are
Simultaneous equation method
Absorbance ratio method
Derivative spectroscopy method.
Chemical Derivatisation Methods.
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Multi-component mode of analysis.
SIMULTANEOUS EQUATION METHOD:6
                         If a sample contains two absorbing drugs (X and Y) each of 
which absorbs at the λmax of the other. It may be possible to determine the 
quantity of both drugs by the technique of simultaneous equation (or) Vierodt’s 
method.
                      Criteria for obtaining maximum precision, based upon absorbance 
ratios have been suggested that place limits on the relative concentrations of the 
component of the mixture.
A2 / A1 and ay2 / ay1
ax2 / ax1 A2 / A1
Where ax1, ax2 = Absorptivities of X at λ1 and λ2
ay1, ay2 = Absorptivities of X at λ1 and λ2
A1, A2 = Absorbances of the diluted sample at λ1 and  λ2.
The ratio should lie outside the range of 0.1 – 2.0 for the precise determination 
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of (Y and X) two drugs respectively.
                      These criteria are satisfactory only when the λmax of the two 
components is reasonably dissimilar. The additional criteria includes that two 
components do not interact chemically, there by negating the initial assumption 
that the total absorbance is the sum of the individual absorbance’s.
ABSORBANCE RATIO METHOD
                 
              This method depends on the property of a substance which obeys 
Beer’s law at all wavelengths, the ratio of absorbance at any two wavelengths is 
a constant value independent of concentration or path length. Two different 
dilutions of the same sample give the same absorbance ratio; this ratio is 
referred to as a ‘Q’ value.
DERIVATIVE SPECTROSCOPIC METHOD:
                    This method involves the conversion of normal spectrum to its first, 
second or higher derivative spectrum. The transformations that occur in the 
derivative spectra are understood by reference to a Gaussian band which 
represents an ideal absorption band.
                    For the purpose of spectral analysis to relate chemical structure to 
electronic transition and for analytical situations in which mixtures contribute 
interfering absorption, a method of manipulating the spectral data called 
derivative spectroscopy was developed.
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                   In this technique spectra are obtained by plotting the first or higher 
derivation of absorbance or transmittance with respect to wavelength versus 
wavelength. Often these plots reverse spectral details, with respect to 
wavelength versus wavelength. Often these plots reverse spectral details, which 
is lost in an ordinary spectrum. In addition concentration measurements of an 
analyte in the presence of their interference can sometimes be made easily or 
more accurately.
              
             Enhanced resolution, band width discrimination are the advantages of 
derivative spectrophotometry that permit the selective discrimination of certain 
absorbing substances in samples in which non specific interferences may 
prohibit the application of simple spectrophotometric methods.
CHEMICAL DERIVATISATION METHOD:
                      Indirect spectrophotometric assays are based on the conversion of 
the analyte by a chemical reagent to a derivative that has different spectral 
properties.
        
         This method is employed If the analyte absorbs weekly in the UV-region, 
a more sensitive method of assay is obtained by converting the substance to a 
derivative with a more intensely absorbing chromophore.
The interference from irrelevant absorption may be avoided by converting the 
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analyte to its derivative which absorbs in the visible region where irrelevant 
absorption is negligible.
                     Indirect spectrophotometric procedure is also used to improve the 
selectivity of the assay of an ultra violet absorbing substance in a sample that 
contains other UV-absorbing components.
               
Assay as single component sample:-
The concentration of a component in a sample which contains other 
absorbing substances may be determined by a simple spectrophotometric 
measurement of absorbance.
Assay as a single component sample for interference :-
If the identityl, concentration and absorptivity of the absorbing 
interferents are known. It is possible to calculate their contribution to the total 
absorbance of a mixture.
The concentration of the absorbing component of interest is then 
calculated from the corrected absorbance, (total absorbance minur the 
absorbance of the interfering substances) in the usual way.
Difference spectrophotometry:-
Difference spectrophotometric assay is that the measured value is the 
difference absorbance (AA) between two equimolar solutions of the analyte in 
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different chemical forms which exhibit different spectral characteristics.
The criteria for applying difference spectrophotometry to the assay of a 
substance in the presence of other absorbing substances are 
1) reproducible changes may be induced in the spectrum of the analyte 
     by the addition of one or more  reagents. 
           
          2) The absorbance of the interfering substances not altered by reagents.
27
                 
                                 CHROMATOGRAPHY 7,8
.          Modern pharmaceutical formulations are complex mixtures containing 
one or more therapeutically active ingredients. to a number of inert materials 
like diluents, disintegrants, clourants and flavours. In order to ensure quality  
and stability of the final product, the pharmaceutical analyst must be able to 
seperate the mixutres into individual components prior to quantitative analysis.
Amongst the most powerful techniques available to the analyst for the 
seperation of these mixutres, a group of highly efficient methods which are 
collectively called as chromatography.
It’s a group of technique which works on the principle of seperation of 
compounents of a mixutre into individual components, depending on their 
effinities for the soluties between two immicible phases. one of the phases is 
affixed bed of large surface area, white the other is a fluid, which moves 
through the surface of the fixed phase. The fixed phase is called statinary phase 
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and the other is termed as the mobile phase.
Depending on the type of chromatography employed, the mobile phase 
may be a pure liquid or a mixture of solutions (eg. Buffer) or it may be gas 
(pure or homogenous mixture) 
Classification of chromatograpy:-
It can classified into five types based on the type of equilibrium process.
The different type of chromatography are
1. Adsorption chromatography
2. Partition chromatography
3. Ion exchange chromatography
4. Size exclusion or gel permeation chromatography
5. Affinity chromatography
 
               The modern instrumental techniques GLC, HPLC and HPTLC 
provide excellent sepration and allow accerate assay of very low 
concentrations of wide variety of substance in complex mixtures. 
Adsorption chromatography:- 
                        In adsorption chromatography, the mobile phase containing the 
dissolved solutes passes over the surface of the stationary phase. Retention of 
the component and their consequent separation depends on ability of the solutes 
from the mobile phase and adsorb them temporarily by means of electrostatic 
forces. Usually silica or alumina is utilized as the adsorbent with relatively non 
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polar solvents such as hexane as the mobile phase in normal phase adsorption 
non where as in reversed beds with relative polar solvents such as water, 
acetonitile and methamol are used as mobile phase.
Partition chromatography:-
     
               In partition chromatography an inert solid material such as silica get or 
diatomaceous earth serves to support a thin layer of liquid which is the effective 
stationary phase. As the mobile phase containing the solutes parses in close 
proximity to this liquid phase, retention and sepration occurs due to the 
solubility of the analytes in the two fluids as determined by their partition co 
efficients. 
The method sffers from dis advantage due to some solubility of stationary 
phase in the mobile phase. Hence precautions must be taken to limit dissolution 
of stationary phase. 
Ion Exchange chromatography:-
In ion exchange chromatography the stationary phase consist of a 
polymeric resinmatrix on the suface of ionic functional groups, eg. Carboxylic 
acids or quaternany ammes have been bonded chemically. As the mobile phase 
passes over this surface, ionic solutes are retained by forming electrostatic 
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chemical bonds with the functional groups. The mobile phase used in this type 
is always liquid.
Size exclusion chromatography:-
        In size exclusion chromatography the stationary phase is a polymeric 
substance containing numerous pores of mole cular dimensions. Solutes whose 
molecular size is sufficiently small will leave the mobile phase to diffrue into 
the pores. Large, remain in the mobile phase and are not retained. This method 
is mostly suitable for the separation of mixtures in which the solutes vary 
considerably in molecular size. The mobile phase in this type may either liquid 
or gaseous.  
Affinity chromatography:-
                This technique utilizes highly specific interaction between one kind of
Solute molecule and a second molecule covalently attached to the stationary 
phase.
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High performance liquid chromatography: 9, 10
         The technique of high performance liquid chromatography (HPLC) 
was developed in the late 1960s and early 1970s.The technique is based on the 
same modes of separation as classical column chromatography, i.e. adsorption, 
partition (including reversed-phase partition), ion exchange and gel permeation.
Apparatus:
        The mode of operation of this system is isocratic, i.e.one particular 
solvent or mixture is pumped throughout the analysis. For some determinations 
the solvent composition may be altered gradually to give gradient elution.
Pumps:
      Pumps are required to deliver a constant flow of mobile phase at 
pressures ranging from 1 to 550 bar. Mechanical pumps of the reciprocating 
piston type give a pulsating supply of mobile phase. A damping device is 
therefore required to smooth out the pulses so that excessive noise at high levels 
of sensitivity or low pressures does not detract from detection of small 
32
quantities of sample. This type of pump is extremely useful, however, in that a 
constant volume of liquid is delivered, the actual value being set by adjustment 
of piston stroke. 
Dual-piston reciprocating pumps produce an almost pulse-free flow 
because the two pistons are carefully phased so that as one is filling the other is 
pumping. These pumps are more expensive than single piston pumps but are of 
benefit when using a flow-sensitive detector such as an ultraviolet or refractive 
index detector.
Modern injectors are based on injection valves which allow the sample at 
atmospheric pressure to be transferred to the high-pressure mobile phase 
immediately before the column inlet. The design of different valves varies 
widely but a typical arrangement is with the injector in the LOAD position, the 
sample is injected from a syringe through a needle port into the loop. The valve 
lever is then turned through 600 to the INJECT position and the sample is swept 
into the flowing mobile phase. If an excess of sample is flushed through the 
loop in the LOAD position, the volume injected is the volume of the loop, 
which is typically 10-20 μl for analytical separations and 0.1-1 ml for semi-
preparative or preparative separations. This complete filling procedure offers 
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the analyst the highest reproducibility, and is capable of giving relative standard 
deviations of less than 0.2%.   
      
Detectors: 
                  It should be sensitive to at least 10-8g ml-1 and give a linear 
response over a wide concentration range. It should also have a low dead 
volume to reduce further band-broadening of the components in the detector 
and 
good stability to prevent fluctuations of the response. The most commonly used 
detectors in the HPLC analysis of pharmaceutical substances are described 
below.
     These normally operate in the ultraviolet region of the spectrum and 
are the most extensively used detectors in pharmaceutical analysis. Photometric 
detectors are of five principal types:
Single wavelength detectors: Equipped with a low-pressure mercury discharge 
lamp. The absorbance is measured at the most intense resonance wavelength of 
mercury at 254nm.
Multi-wavelength detectors: 
   
             Employ mercury and other discharge sources which, when used in 
34
combination with interference filters  allow a number of monochromatic 
wavelengths to be selected, e.g. 206, 226, 280, 313, 340 or 365 nm.
Variable wavelength detectors: use a deuterium light source and a grating 
monochromator to allow selection of any wavelength in the deuterium  (190-
360nm)
Programmable detectors: 
          
             Allow the automatic change of wavelength between and during 
chromatographic analysis.
Diode array detectors: 
                Are microprocessor-controlled photodiode array spectrophotometers 
in which light from an ultraviolet source passes through the flow cell into a 
polychromator which disperses the beam so that the full spectrum fall on the 
array of diodes. Each diode detects light at a discrete wavelength and the array 
provides an almost instantaneous absorption spectrum of the solute in the eluate. 
Fluorescence detectors:
     These are essentially filter fluorimeters or spectrofluorimeters 
equipped with grating monochromators, and micro flow cells. Their sensitivity 
depends on the fluorescence properties of the components in the eluate. 
Refractive index detectors:
       These are differential refractometers which respond to the change in 
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the bulk property of the refractive index of the solution of the component in the 
mobile solvent system. The refractive index detector is the closest approach to 
the universal detector in that some solvent is usually available in which the 
sample gives rise to a measurable difference in refractive index between solvent 
and solution.
Electrochemical detectors:
           These are based on standard electrochemical principles involving 
amperometry, voltametry and polarography.
 Columns:     
      HPLC columns are made of high quality stainless steel , polished 
internally to a mirror finish. Standard analytical columns are 4-5mm internal 
diameter and 10-30 cm in length.  Shorter columns (3-6cm in length) containing 
a small particle size packing material (3 or 5μm) produce similar or better 
efficiencies, in terms of the number of theoretical plates(about 7000), that those 
of 20 cm columns containing 10μm  irregular particles and are used  when short 
analysis times and high throughput of samples are required.
                 Micro bore columns of 1-2 mm internal diameter and 10-25cm in 
length have certain advantages of lower detection limits and lower consumption 
of solvent, the latter being important if expensive HPLC-grade solvents are 
used. HPLC may also be carried out on the semi- preparative or preparative 
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scales by using columns of 7-10mm or 20-40mm internal diameter respectively.
PRINCIPLES OF OPERATION:
Adsorption HPLC:
      Unmodified silica has proved to be the most widely used in HPLC. It 
offers high efficiency and a high permeability which allows normal operating 
pressures of less than 2000 psi to be used. The functional group responsible for 
adsorption is the silanol (Si-OH) group, which interacts with the sample solutes 
by hydrogen bonding. There is therefore increasing retention of solutes with 
increasing solute polarity. Alumina is used as an adsorbent less frequently than 
silica, although for some separations, in particular of aromatic substances and of 
structural isomers, greater selectively is obtained with alumina.
Partition HPLC:
      Packing materials based on silica are also used in partition 
chromatography. Early applications of partition HPLC involved coating the 
silica (in this case acting as a support) with a polar liquid stationary phase, e.g. 
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ethane-1, 2-diol, and using as the mobile phase a less polar solvent or mixture of 
solvents saturated with the stationary phase to avoid the loss of the stationary 
phase by dissolution in the mobile phase. Such packing materials have now 
been replaced by silica to which polar phases are chemically bonded. Examples 
of the functional groups in these chemically bonded partition HPLC packing 
materials are:
Si (CH2)3          O       CH2          CH      CH2 e.g. LiChrosorb Diol
         OH OH
Si (CH2)3       CN e.g. μ Bondpak CN
Si (CH2)3       NH2 e.g. Polygosil NH2
                       The order of increasing polarity of these is diol: cyano : amino. 
This type of chromatography, in which the mobile phase is less polar than the 
stationary phase, is called normal-phase partition chromatography. As the 
adsorption chromatography, substances are eluted in the order of their 
increasing polarities, i.e. the least polar substance is eluted first.
In reversed-phase partition HPLC the relative polarities of the stationary 
and mobile phases are the opposite to those in normal-phase HPLC, i.e. the 
stationary phase is less polar than the mobile phase, and consequently the 
solutes are eluted in the order of their decreasing polarities. The stationary 
phase 
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is silica, chemically bonded through a siloxane        (Si  O  Si  C) linkage to a 
low polar functional group. These phases are prepared by treating the surface 
silanol groups of silica with an organochlorosilane reagent:   
        CH3                                                      CH3                                                           
                   
        Si      OH + CI        Si       R              Si      O      Si       R + HCI
       CH3  CH3 
where R = C6H13 (hexyl), C8H17 (octyl) or C18H37 (octadecyl). 
Untreated silanol groups may be ‘capped’ by treatment with 
trimethylchlorosilane to eliminate adsorption effects 
Mobile phase in RP-HPLC:
The mobile phase in reversed-phase HPLC generally comprises water and 
a less polar organic solvent modifier, e.g. methanol or acetonitrile. Separations 
in these systems are considered to be due to different degrees of hydrophobicity 
of the solutes, the less polar solutes partitioning to a greater extent into the non-
polar stationary phase and consequently being retained on the column longer 
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than the more polar solutes. The rate of elution of the components is controlled 
by the polarity of the organic modifier and its proportion in the mobile phase. 
The rate of elution is increased by reducing the polarity, e.g. by increasing the 
proportion of the organic solvent or by using acetonitrile instead of methanol. 
The simple alteration of the composition of the mobile phase or of the flow rate 
allows the rate of elution of the solutes to be adjusted to an optimum value and 
permits the separation of a wide range of chemical types. 
       For example, the retention time of carboxylic acids is increased by 
reducing the pH with phosphoric acid, acetic acid or buffers. Conversely, the 
retention of nitrogenous bases is increased by raising the pH. As the pH limits 
for reversed-phase columns are pH 2-7.5, the overall retention of substances 
with pKa values near the extremes of this range is made by adjusting both pH 
and solvent polarity ion pair RP-HPLC.
Ion-pair rp-hplc:
      The partition coefficients of ionic and ionisable species between the 
non-polar stationary phase and the polar mobile phase can also be markedly 
affected by the presence of certain oppositely charged ions (counter ions) in the 
mobile phase. This effect is used in ion-pair reversed-phase HPLC. The 
principle, which is the same as that of the acid-dye technique in 
spectrophotometric analysis, is that a counter ion is added to the mobile phase, 
which forms an ion-pair renders it more hydrophobic and results in an increased 
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retention of the solute. Tetramethylammonium or tetrabutylammonium ions are 
used as counter ions for organic acids, and heptane sulphonate or dodecyl 
sulphonate (C12H25So3-) ions are used as counter ions for nitrogenous bases. 
Ion exchange HPLC:
Packings for ion exchange HPLC are based on the cross-linked 
polystyrene-divinyl benzene resins or on ion exchange residues chemically 
bonded to silica.
           Most ion exchange HPLC is carried out in aqueous media although the 
bonded phases can be used with mixtures of aqueous buffers and organic 
solvents if the solutes show poor water solubility.
Size exclusion HPLC:
Cross-linked polystryrene-divinylbenzene resins or silica microspheres 
(5-15 μm in diameter) are used to fractionate materials of high molecular 
weight. A single aqueous or organic solvent is used as the mobile phase and the 
desired retention of solutes on the column is achieved by the choice of the 
appropriate grade of the packing material for the molecular weight range of the 
solutes in the sample.
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VALIDATION 11,12,13,14
                       "Validation of an analytical method is the process by which it is 
established by laboratory studies, that the performance characteristics of the 
method meet the requirements for the intended analytical application .
                 Validation is required for any new or amended method to ensure that 
it is capable of giving reproducible and reliable results, when used by different 
operators employing the same equipment in the same or different laboratories. 
The type of validation programme required depends entirely on the particular 
method and its proposed applications.
Typical analytical parameters used in assay validation include:
1. Precision
2. Accuracy
3. Linearity
4. Range
5. Ruggedness
6. Limit of detection
7. Limit of quantitation
8. Selectivity
9. Specificity
Precision
              The precision of an analytical method is the degree of agreement 
among individual test results obtained when the method is applied to multiple 
sampling of a homogenous sample .
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             Precision is a measure of the reproducibility of the whole analytical 
method (including sampling, sample preparation and analysis) under normal 
operating circumstances.
             Precision is determined by using the method to assay a sample for a 
sufficient number of times to obtain statistically valid results (ie between 6 - 1 
0). The precision is then expressed as the relative standard deviation
                          
                          std dev x 100%
       %RSD = ---------------------------------
                                 Mean
               An example of precision criteria for an assay method is that the 
instrument precision (RSD) will be 1% and the intra-assay precision will be,, 
2%.
2.2 Accuracy
   
             Accuracy is a measure of the closeness of test results obtained by a 
method to the true value. 
               Accuracy indicates the deviation between the mean value found and 
the true value. lt is determined by applying the method to samples to which 
known amounts of analyte have been added. These should be analysed against 
standard and blank solutions to ensure that no interference exists. The accuracy 
is then calculated from the test results as a percentage of the analyte recovered 
by the assay.
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           Accuracy and precision are not the same, as the diagram below indicates. 
A method can have good precision and yet not be accurate.
                Errors in measurement can be divided into two general categories: 
systematic errors and random errors.
               Systematic errors result from sources that can be traced to the 
methodology, the instrument or the operator, and affect both the accuracy and 
the precision of the
measurement.
              Random errors only affect the precision, and are difficult to eliminate, 
because they are the result of random fluctuations in the measured signal, due to 
noise and other factors.
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              Whilst systematic errors are proportional to the sum of individual 
contributions, random errors are proportional to the root of the sum of the 
squares of the individual contributions.Thus, the imprecision of the entire 
procedure is often dominated by the random errors of the most imprecise step.
                
                      Accuracy is usually determined in one of four ways. First, 
accuracy can be assessed by analyzing a sample of known concentration and 
comparing the measured value to the true value. National Institute of Standards 
and Technology (NIST) reference standards are often used; however, such a 
well characterized sample is usually not available for new drug-related analytes. 
The second approach is to compare test results from the new method with 
results from an existing alternate method that is known to be accurate. Again, 
for pharmaceutical studies, such an alternate method is usually not available. 
The third and fourth approaches are based on the recovery of known amounts of 
analyte spiked into sample matrix. 
The third approach, which is the most widely used recovery study, is performed 
by spiking analyte in blank matrices. For assay methods, spiked samples are 
prepared in triplicate at three levels over a range of 50-150% of the target 
concentration. If potential impurities have been isolated, they should be added 
to the matrix to mimic impure samples. 
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The fourth approach is the technique of standard additions, which can 
also be used to determine recovery of spiked analyte. This approach is used if it 
is not possible to prepare a blank sample matrix without the presence of the 
analyte. This can occur, for example, with lyophilized material, in which the 
speciation in the lyophilized material is significantly different when the analyte 
is absent.
Accuracy criteria for an assay method is that the mean recovery will be 
100 +2 % at each concentration over the range of 80-120% of the target 
concentration.
Linearity
                 This is the method's ability to obtain results which are either directly, 
or after mathematical transformation proportional to the concentration of the 
analyte within a given range.
                 Linearity is determined by calculating the regression line using a 
mathematical treatment of the results (ie least mean squares) vs analyte 
concentration.
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                   A linearity study verifies that the sample solutions are in a 
concentration range where analyte response is linearly proportional to 
concentration. For assay methods, this study is generally performed by 
preparing standard solutions at five concentration levels, from 50 to 150% of 
the 
target analyte concentration. Five levels are required to allow detection of 
curvature in the plotted data. The standards are evaluated using the 
chromatographic conditions determined during the specificity studies.
        Standards should be prepared and analyzed a minimum of three 
times. The 50 to 150% range for this study is wider than what is required by the 
FDA guidelines. In the final method procedure, a tighter range of three 
standards is generally used, such as 80, 100, and 120% of target; and in some 
instances, a single standard concentration is used.
                   Validating over a wider range provides confidence that the routine 
standard levels are well removed from nonlinear response concentrations, that 
the method covers a wide enough range to incorporate the limits of content 
uniformity testing, and that it allows quantitation of crude samples in support of 
process development.
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        Acceptability of linearity data is often judged by examining the 
correlation and y-intercept of the linear regression line for the response versus 
concentration plot. A correlation coefficient of >0.999 is generally considered 
as evidence of acceptable fit of the data to the regression line. The y-intercept 
should be less than a few percent of the response obtained for the analyte at the 
target level.
 Range
                 The range of the method is the interval between the upper and lower 
levels of an analyte that have been determined with acceptable precision, 
accuracy and linearity. It is determined on either a linear or nonlinear response 
curve (ie where more than one range is involved, as shown below) and is 
normally expressed in the same units as the test results.
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Limit of Detection
          
          This is the lowest concentration in a sample that can be detected, but not 
necessarily quantitated, under the stated experimental conditions. The limit of 
detection is important for impurity tests and the assays of dosages containing 
low drug levels and placebos.
                The limit of detection is generally quoted as the concentration 
yielding a signal-to-noise ratio of 2:1 and is confirmed by analyzing a number 
of samples near this value (6) using  the following equation.
 Based on the standard deviation of the response and the slope, the detection 
limit (DL) may be expressed as
                                  
DL= 
3.3
S
σ
Where 
σ = standard deviation of the response
S= slope of the calibration curve (of the analyte)
              .
                 Since the limit of detection is dependant on the signal-to-noise ratio, 
it can be improved by enhancing the analyte signal and reducing the detector 
noise. The signal (ie peak height) can be increased by selecting the optimum 
monitoring wavelength, increasing the injection volume or mass (below signal 
or column saturation), increasing the peak sharpness with high efficiency 
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columns and by optimizing the mobile phase. For absorbance detectors, longer 
path lengths in the flow cell enhances sensitivity though often to the detriment 
of post column dispersion.
    
            Noise can be reduced by using high sensitivity detectors with low noise 
and drift characteristics, slower detector response time, mobile phases with low 
absorbance and pumps with low pulsation.
Limit of Quantitation
              This is the lowest concentration of analyte in a sample that can be 
determined with acceptable precision and accuracy.
              lt is quoted as the concentration yielding a signal-to-noise ratio of 1 0: 
1 and is confirmed  by analyzing a number of samples near this value.
              Based on the standard deviation of the response and the slope, 
quantitation limit may be expressed as 
                             
QL= 
10
S
σ
Where 
σ = standard deviation of the response 
S = slope of the calibration curve ( of the analyte)
45
Stability:
During the earlier validation studies, the method developer gained some 
information on the stability of reagents, mobile phases, standards, and sample 
solutions. For routine testing in which many samples are prepared and analyzed 
each day, it is often essential that solutions be stable enough to allow for delays 
such as instrument breakdown or overnight analyses using auto samplers. At 
this point, the limits of stability should be tested. Samples and standards should 
be tested over a least a 48-hrs period, and quantitation of components should be 
determined by comparison to freshly prepared standards. If the solutions are not 
stable over 48-hrs, storage conditions or additives should be identified that can 
improve stability.
                 An example of stability criteria for assay methods is that sample and 
standard solutions and the mobile phase will be stable for 48 hrs under defined 
storage conditions. Acceptable stability is 2% change in standard or sample 
response, relative to freshly prepared standards. The mobile phase is considered 
to have acceptable stability if aged mobile phase produces equivalent 
chromatography (capacity factors, resolution, or tailing factor) and assay results 
are within 2% of the value obtained with fresh mobile phase.
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Specificity
             
             Specificity for an assay ensures that the signal measured comes from 
the substance of interest, and that there is no interference from excipient and/or 
degradation products and/or impurities.
For chromatographic methods, developing a separation involves 
demonstrating specificity, which is the ability of the method to accurately 
measure the analyte response in the presence of all potential sample 
components. The response of the analyte in test mixtures containing the analyte 
and all potential sample components (placebo formulation, synthesis 
intermediates, excipients, degradation products, process impurities, etc.) is 
compared with the response of a solution containing only the analyte. Other 
potential sample components are generated by exposing the analyte to stress 
conditions sufficient to degrade it to 80-90% purity. For bulk (0.1 N NaOH), 
and oxidant (3% H2O2) are typical. For formulated products, heat, light, and 
humidity (85%) are often used.
The resulting mixtures are then analyzed, and the analyte peak is 
evaluated for peak purity and resolution from the nearest eluting peak. If an 
alternate chromatographic column is to be allowed in the final method 
procedure, it should be identified during these studies. 
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                 Once acceptable resolution is obtained for the analyte and potential 
sample components, the chromatographic parameters, such as column type, 
mobile-phase composition, flow rate, and detection mode, are considered set.
           Specificity criteria for an assay method is that the analyte peak will have 
baseline chromatographic resolution of at least 1.5 from all other sample 
components. If this cannot be achieved the unresolved components at their 
maximum expected levels will not affect the final assay result by more than 
0.5%.
               Determination of this can be carried out by assessing the peak identity 
and purity.
             The purity index is a measure of the peak's relative purity, measured 
using a full  comparison of spectral data for the leading and training edge of the 
peak Figure 4. A value of 1.5 is commonly accepted to indicate a pure peak but 
>1.5 would indicate the presence of an impurity, (9) as shown in Figure 5.
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    Figure 5:Spectral comparison showing peak purity
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SYSTEM SUITABILITY TESTS (SST)
                    Once a method or system has been validated the task becomes one 
of routinely checking the suitability of the system to perform within the 
validated limits. The simplest form of an HPLC system suitability test involves 
a comparison of the chromatogram trace with a standard trace (as shown 
below). This allows a comparison of the peak shape, peak width, baseline 
resolution.
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                   Alternatively these parameters can be calculated experimentally to 
provide a quantitative system suitability test report:
Number of theoretical plates (efficiency)
Capacity factor,
Separation (relative retention)
Resolution,
Tailing factor
Relative Standard Deviation (Precision)
These are measured on a peak or peaks of known retention time and peak width.
Plate number or number of theoretical plates (n)
                
               This a measure of the sharpness of the peaks and therefore the 
efficiency of the column. This can be calculated in various ways, for example 
the USP uses the peak width at the base and the BP at half the height.
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Plate number calculation
where
         
          Wh = peak width at 1/2 peak height
         
           Wb = peak width at base
         
               t = retention time of peak
 
                  Therefore the higher the plate number the more efficient the column.
The plate number depends on column length - ie the longer the column the 
larger the plate number.
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                  Therefore the column's efficiency can also be quoted as:
Either- as the plate height (h), or the height equivalent to one theoretical plate 
(HETP).
      L         where L = length of column n Or- as plates/meter
h=-----
      n
.
Capacity factor (capacity ratio) k
               This value gives an indication of how long each component is retained 
on the column (ie how many times longer the component is retarded by the 
stationary phase than it spends in the mobile phase).
53
k' is used in preference to retention time because it is less sensitive to 
fluctuations in chromatographic conditions (ie flow rate) and therefore ensures 
greater reproducibility from run to run.
              In practice the k value for the first peak of interest should be >l to 
assure that it is separated from the solvent.
3.3 Separation Factor (relative retention)
This describes the relative position of two adjacent peaks. ldeally, it is 
calculated using the capacity factor because the peaks' separation depends on 
the components' interaction with the stationary phase.
Therefore considering peaks A and B
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Separation factor calculation
k for the later peak is always placed in the numerator to assure a value 
>l.
             lf the capacity factor is used then the separation factor should be 
consistent for a given column, mobile phase, composition and specified 
temperature, regardless of the instrument used.
NB. The separation factor gives no indication of the efficiency of the column.
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Peak Resolution R
          This is not only a measure of the separation between two peaks, but also 
the efficiency of the column. It is expressed as the ratio of the distance between 
the two peak maxima. (At) to the mean value of the peak width at base (Wb).
Peak resolution calculation
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Tailing factor T
          This is a measure for the asymmetry of the peak.
Tailing Factor calculation
Ruggedness
               Ruggedness is the degree of reproducibility of results obtained by the 
analysis of the same sample under a variety of normal test conditions ie 
different analysts, laboratories, instruments, reagents, assay temperatures, small 
variations in mobile phase, different days etc. (ie from laboratory to laboratory, 
from analyst to analyst.)
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Reproducibility:
The last type of precision study is reproducibility which is determined by 
testing homogeneous samples in multiple laboratories, often as part of inter 
laboratory crossover studies. The evaluation of reproducibility results often 
focuses more on measuring bias in results than on determining differences in 
precision alone. Statistical equivalence is often used as a measure of acceptable 
inter laboratory results. An alternative, more practical approach is the use of 
“analytical equivalence” in which a range of acceptable results is chosen prior 
to the study and used to judge the acceptability of the results obtained from the 
different laboratories.
An example of reproducibility criteria for an assay method could be that 
the assay results obtained in multiple laboratories will be statistically equivalent 
or the mean results will be within 2% of the value obtained by the primary 
testing lab.
Robustness:
           The robustness of a method is its ability to remain unaffected by small 
changes in parameters such as percent organic content and pH of the mobile 
phase, buffer concentration, temperature, and injection volume. These method 
parameters may be evaluated one factor at a time or simultaneously as part of a 
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factorial experiment. Obtaining data on the effects of these parameters may 
allow a range of acceptable values to be included in the final method procedure. 
For example, if column performance changes over time, adjusting the mobile-
phase strength to compensate for changes in the column may be allowed if such 
data are included in the validation.
Performing a thorough method validation can be a tedious process, but 
the quality of data generated with the method is directly linked to the quality of 
this process. Time constraints often do not allow for sufficient method 
validations. Many researchers have experienced the consequences of invalid 
methods and realized that the amount of time and resources required to solve 
problems discovered later exceeds what would have been expended initially if 
the validation studies had been performed properly.    
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STATISTICAL PARAMETERS: 
Statistics consists of a set of methods and rules for organizing and 
interpreting observations.
γ
m
=
=
Σ(X- ) (Y- )X Y
Σ(X- ) (Y- )X Y
Σ(X- )  (Y- )X Y2 2
Σ(X- )X 2
Slope (m)
(σ) = Σ(X- )X 2
n-1
R.S.D (%) = S.D 
X
x 100
Lineanrity coefficient (  γ)
Standard deviation (σ)
                                                   SD
               Standard error(SE) = ---------
                                                             √n
                                    Intercept (c)  = y – m x
where
Σ= Sum of observation 
X= Mean of arithmetic average (Σx/n)
X= Individual observed value.
x-x= Deviation of a value from the mean.
N= Number of observation               
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R.S.D=Relative standard deviation
Information on Sample, 
Define Separation Goals
Need for Special HPLC Procedure, 
Sample Pretreatment, etc?
Choose Detector and  Detector Settings
Choose HPLC Method, Preliminary Run, 
Estimate Best Separation Conditions
Optimize Separation Conditions
Check for problems (or) 
Requirement for special procedure 
Recover Purified Material Quantitative Calibration Qualitative Method
Validation for Release to laboratory
DEVELOPMENT OF REVERSE PHASE HPLC METHOD6
                    “Validation does not make a method good or efficient; It merely 
demonstrates that an analytical method performs in accordance with the claims 
made for it”.                
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REVIEW OF LITERATURE
      HYE SUK LEE, et al, Simultaneous determination of aceclofenac 
and diclofenac in human plasma by narrowbore HPLC using column-
switching using acetonitrile-potassium phosphate.15
                   
                Joshi, R.et al. a simple reversed-phase high-performance liquid 
chromatographic method that has been developed and validated for 
simultaneous estimation of acetaminophen, chlorzoxazone, and aceclofenac 
in tablet dosage form. 
                The estimation was carried out on an Luna C18 (5 µm 
× 25 cm × 4.6 mm i.d.) column using a mixture of buffer, methanol, and 
acetonitrile in the ratio 215:130:155 with final pH of 6.5 as a mobile phase, 
at a flow rate of 1.5 ml/min. Ultraviolet (UV) detection was performed at 
275 nm. Total run time was 10 min; these three drugs (acetaminophen, 
chlorzoxazone, and aceclofenac) were eluted at the retention times of 2.055, 
5.096, and 7.605 min respectively.16
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            Prashant Musmade et al, A simple and sensitive high-performance 
liquid chromatographic (HPLC) method was developed for quantification of 
aceclofenac in rat plasma. Ibuprofen was used as an internal standard (IS). 
          The present method used protein precipitation for extraction of 
aceclofenac from rat plasma. Separation was carried out on reversed-phase C18 
column  (250 mm × 4.6 mm, 5 μ) and the column effluent was monitored by 
UV detector at 282 nm. The mobile phase used was methanol-triethylamine (pH 
7.0; 0.3% v/v in Milli-Q water) (60:40%, v/v) at a flow rate of 1.0 mL min−1 (.17)   
                             
                           Shaikh,et al   A simple, rapid, and precise reversed-phase liquid 
chromatographic method is developed for simultaneous determination of 
paracetamol, aceclofenac, and chlorzoxazone in their ternary mixtures of 
commercial pharmaceutical preparation. This method uses a Zorbax SB C18, 
250 x 4.6 mm, 5 microm analytical column. Mobile phase is acetonitrile and 
buffer (40:60, v/v), buffer containing 50 mM orthophosporic acid; pH of the 
buffer is adjusted to 6 with 10% w/v sodium hydroxide solution. The 
instrumental settings are at a flow rate of 1 mL/min; the column temperature 
is 25 degrees C, and detector wavelength is 270 nm.18
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             Burkhard Hinz,et al, a liquid-liquid extraction-based reversed-
phase HPLC method with UV detection was validated and applied for the 
analysis of aceclofenac and three of its metabolites (4 -hydroxy-aceclofenac, 
diclofenac, 4 -hydroxy-diclofenac) in human plasma. 
              The analytes were separated using an acetonitrile-phosphate buffer 
gradient at a flow rate of  1 mL/min, and UV detection at 282 nm. The retention 
times for aceclofenac, diclofenac, 4 -hydroxy-aceclofenac, 4 -hydroxy-
diclofenac and ketoprofen (internal standard) were 69.1, 60.9, 46.9, 28.4 and 
21.2 min, respectively.19
                     KK Srinivasan ,et al, A derivative spectrophotometric 
procedure has been developed for the simultaneous determination of 
individual combination of aceclofenac and tramadol with paracetamol in 
combined tablet preparation. Tablet extracts of the drugs were prepared in 
distilled water. 
                      The zero crossing point technique and the compensation 
technique were used to estimate the amount of each drug in the combined 
formulations, and were compared. The results were found to be accurate and 
free from interferences. The procedure is rapid, simple, nondestructive, and 
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does not require solutions of equations. Calibration graphs are linear 
(r=0.9999), with a zero intercept up to 24 mg/ml of each drug in 
combination with paracetamol. Detection limits at the p = 0.05 level of 
significance were calculated to be 0.5 mg/ml of aceclofenac, tramadol and 
paracetamol respectively.20
                      R Gopinath, et al, A simple, selective, rapid, precise and 
economical reverse phase HPLC method has been developed for the 
simultaneous estimation of paracetamol and aceclofenac from 
pharmaceutical dosage forms. The method was carried out on a Hichrom 
C18 (25 cm×4.6 mm i.d., 5 µ) column with a mobile phase consisting of 
acetonitrile:20 mM phosphate buffer (pH 5.0) (60:40 v/v) at a flow rate of 
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0.8 ml/min. 
                   Detection was carried out at 265 nm. Etoricoxib was used as an 
internal standard. The retention time of paracetamol, aceclofenac and 
etoricoxib was 4.75, 6.44 and 8.83 min, respectively. The developed method 
was validated in terms of accuracy, precision, linearity, limit of detection, 
limit of quantitation and solution stability. The proposed method can be used 
for the estimation of these drugs in combined dosage forms.21
                      MY Momin, et al, A simple, precise, accurate, and validated 
reverse phase HPLC method has been developed for the simultaneous 
estimation of aceclofenac and paracetamol in tablet by reverse phase C-18 
column (Intersile 4.6 mm×25 cm, 10 µm) using acetonitrile: 50 mM NaH 2 
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PO 4 in a ratio of 65:35 (pH adjusted to 3.0 with orthophosphoric acid) as a 
mobile phase at a flow rate of 1.5 ml/min and detection at 276 nm. The 
retention time for aceclofenac and paracetamol was found to be 1.58 and 
4.01 min respectively, and recoveries from tablet were between 99 and 
101%. The method can be used for estimation of combination of these drugs 
in tablets.22
    
                   BHINGE J. R,et al, a stability-indicating assay method for the 
determination of aceclofenac after being subjected to different International 
Conference on Harmonization prescribed stress conditions, such as 
hydrolysis, oxidation, heat, and photolysis. Aceclofenac (2-[2-[2-(2,6-
dichlorophenyl)aminophenyl]acetyl]oxyacetic acid) is decomposed under 
hydrolytic stress (neutral, acidic, and alkaline) and also on exposure to light 
(in solution form). The compound is stable to oxidative stress, heat, and 
photolytic stress (in solid form). The major degradation product is 
diclofenac, which is confirmed through comparison with the standard. 
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                  Separation of the drug from major and minor degradation products is 
achieved on a C-18 column using methanol-0.02% of ortho phosphoric acid 
in a ratio of 70:30.23
                     Yan,et al, A sensitive high-performance liquid chromatographic 
method with fluorescence detection (excitation 435 and emission 515 nm) 
was established and validated for quantification of five anthraquinones 
(aloe-emodin, rhein, emodin, chrysophanol and physcion) in rat plasma. 
Following a single-step liquid-liquid extraction, the analytes and internal 
standard (1,8-dihydroxyanthraquinone) were separated on a reversed-phase 
C(18) column with water-phosphoric acid-methanol as mobile phase at a 
flow rate of 1 mL/min. 
                         The linear ranges of the calibration curves were 6.5-
1300 ng/mL for aloe-emodin, 20-4000 ng/mL for rhein, 40-8000 ng/mL for 
emodin, 15-3000 ng/mL for chrysophanol and 13-2600 ng/mL for physcion. 
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The lower limit of quantification was 6.5 ng/mL for aloe-emodin, 20 ng/mL 
for rhein, 40 ng/mL for emodin, 15 ng/mL for chrysophanol and 13 ng/mL 
for physcion. The mean accuracy was 94.3-105.1% for aloe-emodin, 90.3-
108.8% for rhein, 92.6-106.7% for emodin, 95.8-103.8% for chrysophanol 
and 98.7-101.2% for physcion. The within-batch and between-batch 
precisions were < or = 5.5% and < or = 13.4%, respectively. 
                     This method is suitable for determining the five anthraquinones in 
plasma simultaneously and thus investigating the pharmacokinetics of 
anthraquinones from Xiexin decoction in rats.24
                   Yi, et al, A simple HPLC method using column-switching and 
ultraviolet detection was developed for the simultaneous determination of 
baicalin (BA), rhein (RH) and berberine (BE) in rat plasma. Plasma samples 
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were injected directly onto a Capcell Pak MF C(8) column (150 mm x 4.6 
mm i.d.) to remove protein and to be pre-separated by an isocratic elution 
using 50 mmol/L phosphate sodium (pH 6.85)-acetonitrile (10:1, v/v). After 
the drug-containing fractions were transferred to a Kromasil C(18) column 
(150 mm x 4.6 mm i.d.) by a valve switching step, the valve position was 
switched back and the main separation was performed by an isocratic elution 
using triethylamine adjusted 20 mmol/L phosphoric acid (pH 6.78)-
acetonitrile (4:1, v/v). 
                    The flow rate was always 1.0 mL/min. The calibration 
curve showed excellent linear relationship (r>or=0.9997) over the 
concentration range of 0.4-7.9 microg/mL for baicalin, 0.2-7.8 microg/mL 
for rhein and 0.4-7.7 microg/mL for berberine in rat plasma. The intra- and 
inter-day assay precisions (R.S.D.) of three analytes were in the range of 
0.34-4.3% and the accuracies were between 98.0% and 102.4%. 
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                     Their recoveries were all greater than 95%. The method was 
successfully applied to the multi-constituents plasma concentration-time curve 
study after oral administration of a traditional Chinese medicine prescription 
Xiexin-Tang in rats.25
                      Sílvia H. M. BORGMANN,  et al, develop and validate a 
dissolution test for diacerhein in capsules using spectrophotometric 
method. The dissolution  established conditions were: 900 mL of 
sodium phosphate buffer pH 7.0 with 0.75% of sodium lauryl sulphate 
as dissolution medium, using a basket apparatus at a stirring rate of 
50 rpm.
                    The drug release was evaluated by UV spectrophotometric
method at 258 nm. The method was validated to meet requirements 
for a global regulatory filing. The validation included specificity, 
linearity, precision and accuracy.26
                NAGESHWARA RAO. R, et al an isocratic reversed-phase high-
performance liquid chromatographic (RP-HPLC) method for determination 
and evaluation of purity of mosapride citrate in bulk drugs and 
pharmaceuticals has been developed using Waters Symmetry C18 column 
with acetonitrile:0.024 M orthophosphoric acid (28:72, v/v) adjusted to pH 
3.0 with triethylamine and photodiode array detector set at 276 nm. The 
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method is simple, rapid, selective and capable of detecting all process related 
impurities at trace levels in the finished products with detection limits 
ranging in between 0.2 x 10-8g and 6.4 x 10-8g. 
                   The method has been validated with respect to accuracy, precision, 
linearity, ruggedness, and limit of detection and quantification. The linearity 
range was 125-1000 μg/ml. 
                
              The percentage recoveries from pharmaceutical dosages were ranged 
from 95.53 to 100.7. The method was found to be suitable not only for 
monitoring the reactions during the process development but also quality 
assurance of mosapride citrate.27
                    N. V. S. Ramakrishna,et al ,simple, rapid, sensitive and specific 
liquid chromatography-tandem mass spectrometry method was developed 
and validated for quantification of mosapride (I), a novel and potent 
gastroprokinetic agent that enhances the upper gastrointestinal motility by 
stimulating 5-HT4 receptor. The analyte and internal standard, tamsulosin 
(II), were extracted by liquid-liquid extraction with diethyl ether-
dichloromethane (70:30, v/v) using a Glas-Col Multi-Pulse Vortexer. The 
chromatographic separation was performed on a reversed-phase Waters 
symmetry C18 column with a mobile phase of 0.03% formic acid-
acetonitrile (10:90, v/v). 
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                        The protonated analyte was quantitated in positive 
ionization by multiple reaction monitoring with a mass spectrometer. The 
mass transitions m/z 422.3 198.3 and m/z 409.1 228.1 were used to 
measure I and II, respectively. The assay exhibited a linear dynamic range of 
0.5-100.0 ng/mL for mosapride in human plasma. The lower limit of 
quantitation was 500 pg/mL with a relative standard deviation of less than 
15%. Acceptable precision and accuracy were obtained for concentrations 
over the standard curve ranges. A run time of 2.0 min for each sample made
it possible to analyze a throughput of more than 400 human plasma samples 
per day. The validated method has been successfully used to analyze human 
plasma samples for application in pharmacokinetic, bioavailability or 
bioequivalence studies.28
                            
                         Patel,et al , Simple, sensitive high-performance liquid 
chromatography (HPLC) and thin-layer chromatography (TLC) methods are 
developed for the quantitative estimation of rabeprazole and mosapride in 
their combined pharmaceutical dosage forms. In HPLC, rabeprazole and 
mosapride are chromatographed using 0.01M 6.5 pH ammonium acetate 
buffer-methanol-acetonitrile (40:20:40, v/v, pH 5.70 ± 0.02) as the mobile 
phase at a flow rate of 1.0 mL/min. In TLC, the mobile phase is ethyl 
acetate-methanol-benzene (2:0.5:2.5, v/v). Both the drugs are scanned at 276 
nm. The retention times of rabeprazole and mosapride are found to be 4.93 ± 
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0.01 and 9.79 ± 0.02, respectively. The Rf values of rabeprazole and 
mosapride are found to be 0.42 ± 0.02 and 0.61 ± 0.02, respectively. The 
linearities of rabeprazole and mosapride are in the range of 400-2000 ng/mL 
and 300-1500 ng/mL, respectively, for HPLC; in TLC, the linearities of 
rabeprazole and mosapride are in the range of 400-1200 ng/spot and 300-900 
ng/spot, respectively. The limit of detection is found to be 97.7 ng/mL for 
rabeprazole and 97.6 ng/mL for mosapride in HPLC; in TLC the limit of 
detection is found to be 132.29 ng/spot for rabeprazole and 98.25 ng/spot for 
mosapride. The proposed methods can be applied to the determination of 
rabeprazole and mosapride in combined pharmaceutical products.29
                             Yoichi Aoki ,et al, A simple method for determination of 
mosapride citrate and its metabolite, des-p-fluorobenzyl mosapride (M-1), in 
equine muscle, liver, kidney, adipose tissue and intestine by liquid 
chromatography–tandem mass spectrometry has been developed.
                            (±)-4-Amino-5-chloro-2-ethoxy-N-[[4-(2-chlorobenzyl) 
morpholinyl]methyl]benzamide   was used as an internal standard. The 
analytes and internal standard were spiked and extracted from tissues by 
acetonitrile. The chromatographic separation was performed on a reversed-
phase TSK-GEL SUPER ODS column with a mobile phase of acetonitrile–
0.05% (v/v) formic acid containing 5 mmol/L nonafluoropentanoic acid (2:3, 
v/v). The method exhibited a large linear range from 0.0005 to 0.2 μg/mL 
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for both mosapride citrate and M-1 (r > 0.9976). In the intra-day assay 
(n = 5), the relative standard deviations (RSDs) ranged from 1.1 to 7.8% for 
mosapride citrate and 1.6 to 7.2% for M-1. In the inter-day assay (n = 3), the 
RSDs ranged from 1.0 to 13% for mosapride citrate and 0.8 to 11% for M-1. 
                 The extraction recovery at 1.28 μg/g of mosapride citrate from equine 
tissues ranged from 97 to 107%. The lower limit of quantification for 
mosapride citrate was found to be 0.004 μg/g. Stability studies were carried 
out at different storage conditions.30
                          Zarghi A, et al, A rapid, sensitive and reproducible HPLC 
method was developed and validated for the analysis of pantoprazole (CAS 
102625-70-7) in human plasma. The separation was achieved on a 
monolithic silica column using acetonitrile-potassium dihydrogen phosphate 
buffer (25:75,v/v), pH 3.0, as the mobile phase at a flow rate of 1.5 ml min(-
1). The wavelength was set at 290 nm. The assay enables the measurement 
of pantoprazole for therapeutic drug monitoring with a minimum 
quantification limit of 20 ng ml(-1).31
                        T. Sivakumar*, et al A simple reversed-phase high-
performance liquid chromatographic (RP-HPLC) method has been 
developed and validated for simultaneous determination of domperidone and 
pantoprazole in capsules. The com-pounds were separated on an ODS 
analytical column with a mixture of methanol, acetonitrile, and triethylamine 
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solution (10 mM, pH 7.0 ± 0.05 adjusted with 85% phosphoric acid) in the 
ratio 20:33:47 (v/v) as mobile phase at a flow rate of 1.0 mL min−1.
 UV detection was performed at 285 nm. The method was validated for 
accuracy, precision, specificity, linearity, and sensitivity. 
                    The developed and validated method was successfully used for 
quantitative analysis of Pantop-D capsules. Total chromatographic analysis time 
per sample was approximately 10 min with pantoprazole, acetophenone 
(internal standard), and domperidone eluting with retention times of 4.34, 5.52, 
and 9.46 min, respectively. 
                     Validation studies revea-led the method is specific, rapid, 
reliable, and reproducible. Calibration plots were linear over the 
concentration ranges 0.5–5 μg mL−1 and 1–10 μg mL−1 for domperidone 
and pantoprazole, respectively. The LODs were 15.3 and 3.0 ng mL−1 and 
the LOQs were 51.0 and 10.1 ng mL−1 for domperidone and pantoprazole, 
respectively. The high recovery and low relative standard deviation confirm 
the suitability of the method for deter-mination of domperidone and 
pantoprazole in capsules.32
                 KOCYIGIT-KAYMAKCOGLU ,et al, A rapid and specific high-
performance liquid chromatographic method was developed and validated 
for the simultaneous determination of ketoprofen, valsartan and pantoprazole 
in human plasma. Chromatographic separation of ketoprofen, valsartan and 
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pantoprazole was performed using a Chromasil C18 column (250 mm x 4.6 
mm i.d., 5 μm particle size). 
                       The mobile phase consisted of a mixture of 0.02 M sodium 
dihydrogen phosphate buffer (pH 3.15) and acetonitrile (58:42, v/v) pumped 
through the chromatographic system at a flow rate of 1 mL min-1. The Diode 
Array detector was operated at 225 and 272 nm. Rofecoxib was used as an 
internal standard.
                     Sample treatment procedure consisted of deproteinisation with 
acetonitrile-methanol (50:50 v/v). Analytical recoveries were in the range of 
79.00-118.00% of nominal values of valsartan, ketoprofen and pantoprazole. 
                The method was reproducible and accurate with lower limits of 
quantification 250 μg · L-1 for pantoprazole and 500 μg · L-1 for ketoprofen 
and valsartan. This method was relatively easy to perform and allows 
simultaneous determination of these three drugs in plasma at nanogram 
levels.33
                B. H. Patel, et al,   A simple, sensitive, and precise high 
performance liquid chromatographic method for the analysis of 
pantoprazole, rabeprazole, esomeprazole, domperidone and itopride, with 
ultraviolet detection at 210 nm, has been developed, validated, and used for 
the determination of compounds in commercial pharmaceutical products. 
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The compounds were well separated on a Hypersil BDS C18 reversed-phase 
column by use of a mobile phase consisting of 0.05 M, 4.70 pH, potassium
 dihydrogen phosphate buffer - acetonitrile (720:280 v/v) at a flow rate of 
1.0 mL min−1.
                 The linearity ranges were 400–4,000 ng mL−1 for pantoprazole, 200–
2,000 ng mL−1 for rabeprazole, 400–4,000 ng mL−1 for esomeprazole, 
300–3,000 ng mL−1 for domperidone and 500–5,000 ng mL−1 for itopride. 
Limits of detection (LOD) obtained were: pantoprazole 147.51 ng mL−1, 
rabeprazole 65.65 ng mL−1, esomeprazole 131.27 ng mL−1, domperidone 
98.33 ng mL−1 and itopride 162.35 ng mL−1. The study showed that 
reversed-phase liquid chromatography is sensitive and selective for the 
determination of pantoprazole, rabeprazole, esomeprazole, domperidone and 
itopride using single mobile phase.34
                        Bhavesh H. Patel et al, high-performance liquid 
chromatography (HPLC) and high-performance thin-layer chromatography 
(HPTLC) methods for the simultaneous estimation of pantoprazole (PANT) 
and domperidone (DOM) in pure powder and capsule formulations.
The HPLC separation was achieved on a Phenomenex C18 column (250 mm 
id, 4.6 mm, 5 μm) using 0.01 M, 6.5 pH ammonium acetate buffer-
methanol-acetonitrile (30 + 40 + 30, v/v/v, pH 7.20) as the mobile phase at a 
flow rate of 1.0 mL/min at ambient temperature. The HPTLC separation was 
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achieved on an aluminum-backed layer of silica gel 60F254 using ethyl 
acetate–methanol (60 + 40, v/v) as the mobile phase. Quantification was 
achieved with ultraviolet (UV) detection at 287 nm over the concentration 
range 400–4000 and 300–3000 ng/mL with mean recovery of 99.35 ± 0.80 
and 99.08 ± 0.57% for PANT and DOM, respectively (HPLC method). 
Quantification was achieved with UV detection at 287 nm over the 
concentration range 80–240 and 60–180 ng/spot with mean recovery of 
98.40 ± 0.67 and 98.75 ± 0.71% for PANT and DOM, respectively (HPTLC 
method). These methods are simple, precise, and sensitive, and they are 
applicable for the simultaneous determination of PANT and DOM in pure 
powder and capsule formulations.
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1)                       The combination of an Anti-inflammatory drug 
 
 ACECLOFENAC and an Anti-arthritic drug DIACEREIN are selected for 
analysis by UV spectrophotometric method and reverse phase high performance 
liquid chromatography.
                      It is estimated by simultaneous equation method as the λmax of 
the drugs are dissimilar and their absorbance ratio lies outside the range 0.1 to 2.
                   The next objective is to develop and validate a reverse phase high 
performance liquid chromatography which would be simple, rapid, efficient and 
reliable for the analysis of both the drugs in combined dosage form.
2) The  combination of  Gastroprokinetic agent MOSAPRIDE 
and Proton pump inhibitor PANTOPRAZOLE are selected for analysis by UV 
spectrophotometric method and reverse phase high performance liquid 
chromatography.
                      It is estimated by simultaneous equation method as the λmax of 
the drugs are dissimilar and their absorbance ratio lies outside the range 0.1 to 2.
                   The next objective is to develop and validate a reverse phase high 
performance liquid chromatography which would be simple, rapid, efficient and 
reliable for the analysis of both the drugs in combined dosage form.
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SCHEME OF THE WORK
1.
2.
                
DRUG PROFILE
Aceclofenac,Diacerein 
combined dosage form
UV Simultaneous equation method Reverse Phase High PerformanceLiquid Chromatography
Recovery Studies Validation
Mosapride,Pantoprazole 
Combined Dosage Form
UV Simultaneous Equation Method Reverse Phase High Performance Liquid Chromatography
Recovery Studies Validation
83
ACECLOFENAC 35
Molecular structure:
                 
              
Chemical Name            :  [[[2-[(2,6-    Dichlorophenyl)amino]phenyl]acetyl]    
                                         oxy]acetic acid       
Molecular Formula      :  C16H13Cl2NO4
Molecular Weight        :   354.2
Appearance                   :  White or almost white, crystalline powder
Solubility                       :  Practically insoluble in water, freely soluble in 
                                          acetone, ethanol.
              
Action and use              :  Analgesic; anti-inflammatory
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DIACEREIN 35
  
                        
Molecular structure:
                                          
                                    
Chemical Name            :  1,8-diacetoxy-3-carboxyanthraquinone
Molecular Formula      :  C19H12O8
Molecular weight          :      368.3
Appearance                   :   light yellow colour powder
Solubility                       :    soluble in ethanol      
Action and use              :   Antiarthritic drug
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REVERSE PHASE HIGH PERFOMANCE LIQUID 
CHROMATOGRAPHY AND VALIDATION IN ESTIMATION OF 
ACECLOFENAC AND  DIACEREIN IN COMBINED TABLET 
DOSAGE FORM.
Instruments:
 Shimadzu liquid chromatograph LC – 20 AT VP 
 Mettler Toledo AG 285 Balance CP-225D
 DIGISUN-DI-707 pH meter
 Millipore filter (10.45/ µm)
 Whatman filter paper 
 Sonicator
Reagents and Chemicals
 Acetonitrile
 HPLC grade water
 Buffer
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REFERENCE STANDARDS:
Aceclofenac and Diacerein:
These two reference standards were obtained as gift samples from Ceeall 
analytical  laboratory,Chennai.  The authenticity and purity of the sample was 
certified by the same.
Sample Tablet brand used :  Dycerin-A36
Label claim :   Aceclofenac            -  100 mg
                                                       Diacerein                 -  50 mg
 METHOD DEVELOPMENT AND OPTIMIZATION:
SELECTION OF WAVELENGTH:
The  known  concentration  of  Aceclofenac  and  Diacerein  were  taken  and 
dissolved in THF(Tetra hydro furan). The wavelength were tried from 200nm to 
400nm  and the Peaks of the drugs were showing fronting and tailing.  The peak 
areas were also found to be minimum.
Finally 270nm were selected for the analysis.
OPTIMIZATION OF CHROMATOGRAPHIC PARAMETAERS
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(a) SELECTION OF MODE OF OPERATION:
As both  the  drugs  were  are  polar  in  nature,  a  RP-HPLC method was 
Proposed.
(b) SELECTION AND STANDARDISATION OF MOBILE PHASE:
DYCERIN-A  is  a  combination  of  Aceclofenac  100mg  and 
Diacerein50mg. The method development of Aceclofenac and Diacerein
required adequate resolution of two drug peaks in the chromatogram.
DIFFERENT COMBINATIONS OF BUFFER AND SOLVENTS:
                   Buffer(potassium dihydrogen ortho phosphate  pH:3) and 
acetonitrile     (50:50)
                   Buffer(potassium dihydrogen ortho phosphate  pH:3)  and 
acetonitrile (20:80)          
                   Buffer(potassium dihydrogen ortho phosphate  pH:3) and 
acetonitrile (30:70)
                    Buffer(potassium dihydrogen ortho phosphate pH:3) and methanol 
and acetonitrile (40:30:30),finally add 2.5% v/v THF
                   Buffer(potassium dihydrogen ortho phosphate pH:3) and methanol 
and acetonitrile (45:20:35),finally add 5% v/v THF
                    Peaks of Aceclofenac and Diacerein were well resolved with 
solvent  system  Buffer  (Potassium  dihydrogen  ortho  phosphate  pH:3) 
acetonitrile and methanol.(45:35:20).
SELECTION OF FLOW RATE:             
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The Flow rate for Aceclofenac and Diacerein were tried with 0.5ml, 1ml, 
1.5ml and 2ml, the peaks of the drugs were showing fronting and tailing with 
0.5ml and 2ml respectively and finally 2ml per minute was selected   for the 
analysis. 
PREPARATION OF BUFFER SOLUTION:
Buffer solution was prepared by using 0.136g of potassiumdi hydrogen ortho 
phosphate and 0.01M citric acid in 500ml of HPLC grade water, pH adjusted to 
4 with TEA, filtered through 0.45µ nylon membrane and degassed.
PREPARATION OF MOBILE PHASE:
Mix  the  Buffer,  acetonitrile  and  methanol   in  the   ratio  of 
45:35:20,finally  add  5%  v/v  THF  and  degass  it.   Filtered  through  0.45µ 
membrane.
DILUENT
Mobile phase is used as diluent.
DETERMINATION OF RETENTION TIME:
(A) STANDARD SOLUTION OF ACECLOFENAC:
Accurately  200.2mg of  Aceclofenac  was  taken in  a  100ml  volumetric 
flask and dissolved in 10ml THF,the volume was adjusted to 100ml with mobile 
phase. 5 ml was taken in a separate 50ml volumetric flask and the volume was 
adjusted  to  50  ml  with  mobile  phase  to  get  concentration  of  100µg/ml  of 
Aceclofenac.  20µl  of  this  solution  was  injected  and  chromatogram  was 
obtained.
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(B) STANDARD SOLUTION OF DIACEREIN:
Accurately 100.2mg of Diacerein was taken in a 100ml volumetric flask 
and dissolved in  10ml  THF,the  volume was adjusted  to  100ml  with mobile 
phase. 5 ml was taken in a separate 50ml volumetric flask and the volume was 
adjusted  to  50  ml  with  mobile  phase  to  get  concentration  of  50µg/ml  of 
Diacerein. 20µl of this solution was injected and chromatogram was obtained 
(C) PREPARATION OF MIXED STANDARD SOLUTION:
100.2mg of Diacerin and 200.2mg Aceclofenac was transferred into a 
100ml dried volumetric flask.  The compounds were first dissolved in 10ml of 
THF and it  was  sonicated.   Then  the  volume  was  adjusted  to  100ml  with 
mobile  phase.  From  the  stock  solution  5ml  was  transferred  to  a  50ml 
volumetric flask and the volume was adjusted to 50ml with mobile phase to get 
a concentration of 50µg/ml of Diacerin and 100µg/ml of Aceclofenac . 20 µl 
of the  resulting solution was injected and chromatogram was recorded .
FIXED CHROMATOGRAPHIC CONDITIONS:
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INSTRUMENT              : Shimadzu liquid chromatograph
  LC-20 AT VP    
COLUMN : C18 
WAVELENGTH : 265nm
TEMPERATURE : Ambient temperature.
FLOW RATE : 2ml/min
INJECTION VOLUME : 20µl.
MOBILE PHASE : Buffer (Potassium di hydrogen ortho phosphate 
  pH:3) acetonitrile and methanol.(45:35:20),
                                           finally add 5%v/v THF
RETENTION TIME : 3.52 min for Diacerein ,6.2 min 
  for Aceclofenac
QUANTITATIVE DETERMINATION OF THE DRUGS BY USING THE 
DEVELOPED METHOD
Sample : Dycerin-A
Label Claim : Aceclofenac – 100mg
                               Diacerein      - 50mg
METHOD:
Twenty  tablets  were  weighed  and  powdered.   512.6mg  sample  tablet 
DYCERIN-A(equivalent  to  100.1mg  of  Aceclofenac  and  50.1mg  Diacerein) 
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was taken into 100ml dried volumetric flask.  The powder was first dissolved in 
10ml of THF and sonicated and finally the volume was adjusted to 100ml with 
mobile phase.  From this solution 5ml was transferred to 50ml volumetric flask 
and volume was adjusted to 50ml with mobile phase to get a concentration of 
100µg/ml of Aceclofenac and 50µg/ml of Diacerein. 20µl of the solution was 
injected and the chromatogram obtained.
                                The amount of Aceclofenac and Diacerein present in the 
tablet formulation was calculated by comparing the peak area of the standard 
and reports are given in Table-1
Amount of drug present in the tablet:
 Sample area   Standard dilution      Potency
--------------- x ----------------------- x------------x Average weight  
Standard area   Sample dilution   100
   Amount present
Percentage purity = --------------------x 100
    Label claim
                                                      Table-1
          
Quantitative Estimation
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S.
No.
Brand
Name
Content Label
Claim
(mg)
Peak area Amount 
present
(mg)
Percent
Purity%
w/v
1. DYCERIN-A
Diacerein 50mg 5488.995 49.89 99.78%
Aceclofenac 100mg 4220.921 100.29 100.29%
Acceptance critearia: 98-102%w/v
Assay for Diacerein:
Amount Present = 
5488.99
5
5480.85
2
X
100.2/100x5/50
512.6/100x5/50 X
99.72
100 X 255.6= 49.89 mg
% Label Claim =
 49.89
50 X 100 = 99.78 %
                   
Assay for Aceclofenac: 
Amount Present = 
4220.92
1
4195.15
4
X
200.2/50 x 5/50
512.6/100x5/50 X
99.85
100 X 255.6=100.29 mg
% Label Claim =
 100.29
100 X 100 =100.29 %
VALIDATION
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Validation of an analytical method is a process to establish by laboratory 
studies that the performance characteristics of the method meet the requirements 
for  the  intended  analytical  application.   Performance  characteristics  are 
expressed in terms of analytical parameters.
Design of experiment:
Typical analytical parameters used in assay validation are,
 Specificity
 Linearity and range
 Limit of quantification
 Limit of detection
 Accuracy
 Precision
- System precision
- Method precision
 Robustness
 Ruggedness
 System suitability studies
- Resolution
- Number of theoretical plates
- The tailing factor.
SPECIFICITY
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The specificity of an analytical method is its ability to measure accurately 
and specifically the analytes in the presence of compounds that may be expected 
to be present in the sample matrix.
Determination:
The specificity of the analytical method was determined by injecting the 
placebo solution under the same experimental conditions as the assay.
Preparation of placebo:
Placebo  is  prepared  by  mixing  all  the  excipients  without  active 
ingredients.
Procedure:
 100mg placebo was accurately weighed and transferred into a 25ml 
volumetric flask and the volume was made to 25ml with the mobile 
phase.  The  solution  was  filtered  through Millipore  filter  paper  and 
degassed.  20µl of this solution was injected and chromatogram was 
recorded .
 100.2mg of Diacerin and 200.2mg Aceclofenac was transferred into a 
100ml dried volumetric flask.  The compounds were first dissolved in 
10ml of THF and it was sonicated.  Then the volume was adjusted to 
100ml with mobile phase. From the stock solution 5ml was transferred 
to a 50ml volumetric flask and the volume was adjusted to 50ml with 
mobile  phase  to  get  a  concentration  of  50µg/ml  of  Diacerin  and 
100µg/ml  of  Aceclofenac.  To  this  solution  100mg of  placebo  was 
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added  and it was sonicated ,filtered through a Millipore filter paper. 
20 µl  of the  resulting solution was injected and chromatogram was 
recorded.The  mixed  standard  solution  was  also  injected  without 
placebo and it was recorded  and the reports are shown in Table-9 &10
Table-9
Specificity for Diacerein
S.No. Sample Area obtained
1. Standarad                5480.852
2. Standard+Placebo 5479.520
3. Placebo 0
Table-10
Specificity for Aceclofenac
S.No. Sample Area obtained
1. Standarad 4195.154
2. Standard+Placebo 4196.246
3. Placebo 0
LINEARITY AND RANGE:
Linearity  of an analytical method is its ability to elicit test result that are 
directly proportional to the concentration of analyte in  samples within a given 
range.
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Determination:  
 The linearity of the analytical method was determined by mathematical 
treatment  of  test  result  obtained  by  analysis  of  samples  with  analyte 
concentrations  across the claimed range.   Area was plotted  graphically  as  a 
function of analyte concentration.  Percentage curve fitting was calculated.
Method:
Preparation of mixed standard stock solution
Accurately  weighed  100.2mg  of  Diacerin  and  200.2mg  Aceclofenac  was 
transferred  into  a  100ml  dried  volumetric  flask.   The  compounds were  first 
dissolved in 10ml of THF and then the volume was adjusted to 100ml with 
mobile phase.  From the From the resulting solution,4,  4.5,  5,  5.5,  6ml were 
transferred into 5 different 50ml volumetric flask.  The volume was made with 
mobile phase to get a final  concentration of 80.16,90.18,100.2,110.22,120.24 
µg/ml  of  Diacerein  and  160.16,180.18,200.2,220.22,240.24  µg/ml  of 
Aceclofenac. 20µl of the resulting solution was injected and chromatogram was 
recorded.
Acceptance Criteria
 Correlation coefficient should not be less than 0.99
The  linearity datas and analytical performance parameters of Diacerein 
and Aceclofenac are shown in Table-11- 13 .
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Table-11
LINEARITY DATA
                                                     Diacerein
S.No. Concentration(µg/ml) Peak Area
1. 80.16 4360.112
2.                       90.18 4907.984
3. 100.20            5492.272
4. 110.22 6112.583
5. 120.24            6448.837
Table-12
LINEARITY DATA
                                                      Aceclofenac
S.No. Concentration(µg/ml) Peak Area
1. 160.16 3320.230
2.                      180.18 3736.739
3. 200.20            4186.285
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4. 220.22 4623.256
5. 240.24            5086.729
Table-13
ANALYTICAL PERFORMANCE PARAMETERS
S. no. Drug name
Linear
dynamic
range(µ/ml)
Correlation
coefficient
Slope Intercept
1. Diacerein (80.16-120.24) 0.996 53.71 82.615
2. Aceclofenac (160.16-240.24) 0.999 22.0752 -228.808
ACCURACY
The  accuracy  of  an  analytical  method  is  the  closeness  of  the  results 
obtained by that method to the true value.  Accuracy may often be expressed as 
percent recovery by the assay of known added amount of analyte.
Determination:
The accuracy of the analytical method was determined by applying the 
method to the analysed samples to which known amounts of analyte had been 
added.  The accuracy was calculated from the  test results as the percentage of 
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analyte recovered by the assay.
Acceptance criteria:
Percentage recovery should be within 98-102%
PROCEDURE:
Mixed standard stock solution 5ml and sample stock solution 5ml were mixed 
together in 50 ml volumetric flask and the volume was made upto 50ml with 
mobile phase to get 100% range. Similarly 80% and 120% range was prepared. 
20µl of this solution was injected three times and chromatograms were shown 
in the following graphs and values in table 14 and 15 .
Table-14
                                    Recovery Study of Diacerein
S.No. RANGE Area 
obtained
Amount 
Recovered(mg)
% 
Recovery
1. 80%
4436.412 50.41      100.82
   4443.341         50.49 100.98
4439.341 50.44     100.88
2 100%
   5531.448 50.28 100.56
5517.152 50.15      100.30
   5500.326         50.00 100.00
3 120%
6537.755 49.53 99.06
   6534.844 49.50 99.00
6601.524 50.00 100.00
100
Table-15
                                    Recovery Study of Aceclofenac
S.No. RANGE Area 
obtained
Amount 
Recovered(mg)
% 
Recovery
1. 80%
3389.522 100.66    100.66
   3420.120         101.57    101.57
3397.976 100.90    100.90
2 100%
  4169.926 99.07 99.07
4200.111 99.79      99.79
   4280.002         101.69 101.69
3 120%
5081.058 100.6 100.6
   5076.152 100.5 100.5
5103.123 101.04 101.04
PRECISION
Precision  of  an  analytical  method  is  the  degree  of  agreement  among 
individual  test  results  when  the  procedure  is  applied  repeatedly  to  multiple 
sampling of a homogenous sample.  Precision of analytical method is usually 
expressed as the standard deviation and relative standard deviation.
Determination:
The  precision  of  the  analytical  method  was  determined  by  assaying 
sufficient number of sample and relative standard deviation was calculated.
The precision of the  instrument was determined by assaying the samples 
consecutively, number of time and relative standard deviation was calculated.
Acceptance Criteria:
The relative standard deviation   should be with in 2%
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SYSTEM PRECISION :
Accurately  weighed 100.2mg of  Diacerin  and 200.2mg Aceclofenac  sodium 
was transferred into a 100ml dried volumetric flask.  The compounds were first 
dissolved in 10ml of THF and then the volume was adjusted to 100ml with 
mobile  phase.  From  the  resulting  solution  5ml  was  transferred  into  50ml 
volumetric flask. The volume was made up with mobile phase to 50ml.
Method:
The system precision was evaluated by measuring 6 successive injection 
of  20µl  of  standard  solution.   The  peak  response  were  measured  from the 
following  chromatogram   and  system  precision  data  area  shown  in 
Table-15&16.
METHOD PRECISION:
Procedure
Twenty  tablets  were  weighed  and  powdered.   512.6mg  sample  tablet 
DYCERIN-A(equivalent  to  100.1mg  of  Aceclofenac  and  50.1mg  Diacerein) 
was taken into 100ml dried volumetric flask.  The powder was first dissolved in 
10ml of THF and sonicated and finally the volume was adjusted to 100ml with 
mobile phase.  From this solution 5ml was transferred to 50ml volumetric flask 
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and volume was adjusted to 50ml with mobile phase to get a concentration of 
100µg/ml of Aceclofenac and 50µg/ml of Diacerein. 20µl of the solution was 
injected and the chromatogram obtained is shown in following graph.
                                The amount of Aceclofenac and Diacerein present in the 
tablet formulation was calculated by comparing the peak area of the standard 
and reports are given in Table-17-19
Table-15
System Precision data
S.No. Area of Diacerein Area of Aceclofenac
1. 5481.978           4222.529
2.                5484.719 4194.068
3. 5491.212            4196.643
4. 5499.890 4200.154
5. 5500.224            4163.354
6. 5498.099 4125.231
MEAN 5492.687            4183.663
S.D 7.9790 34.3103
%RSD 0.1452 0.820
Table-16
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Relative 
Standard
Deviation
Diacerein Aceclofenac Acceptance
Criteria
0.1452 0.820 2%
Table-17
Method Precision 0f Diacerein
S.No. Area Obtained Assay value in(mg) %  Label claim w/v
1. 5481.929 49.82 99.64
2. 5469.929 49.68              99.37
3. 5491.016 49.82 99.64
4.        5510.121 49.91              99.82
5. 5488.954               49.72 99.74
6. 5517.952 50.00 100.00
MEAN            5493.316
STANDARD DEVIATION 17.834
RELATIVE STANDARD DEVIAION 0.3246
                                Method Precision 0f Aceclofenac-18
S.No. Area Obtained Assay value in(mg) %  Label claim w/v
1. 4219.969 99.61 99.61
2. 4168.401 99.06              99.06
3. 4196.525 99.67 99.67
4.       4225.467 100.20             100.20           
5. 4185.737              100.21 100.21
6. 4210.123 100.70 100.70
MEAN           4201.037
STANDARD DEVIATION 21.7133
RELATIVE STANDARD DEVIAION 0.5168
                                                    Table-19
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Relative 
Standard
Deviation
Diacerein Aceclofenac Acceptance
Criteria
0.3246 0.5168 2%
Limit of detection (LOD)
It is the lowest amount of analyte in a sample that can be detected  but not 
necessarily  quantities   as  an  exact  value   under   the  stated,  experimental 
conditions.   The detection limit  is  usually  expressed as  the concentration of 
analyte.
It is given by
               3.3 x σ
L.O.D = -----------
                   m
σ = standard deviation of the response
          m= slope of the calibration curve
TABLE-20
LIMIT OF DETECTION
DRUG
STANDARD 
DEVIATION
SLOPE L.O.Dμg/ml
DIACEREIN 7.9790     53.710 0.490
ACECLOFENAC 34.3103 22.075 5.129
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Limit of Quantitation:
The Quantitation limit of an analytical procedure is the lowest amount of 
analyte which can be Quantitatively determined with suitable Precision  and 
Accuracy. 
It is  given by 
                  10xσ
L.O.Q = -------------
                    m
                    
σ = standard deviation of the response
                    m= slope of the calibration curve
TABLE-21
LIMIT OF QUANTITATION
DRUG
STANDARD 
DEVIATION
SLOPE
L.O.Q 
μg/ml
DIACEREIN 7.9790     53.710 1.4855
ACECLOFENAC 34.3103 22.075 15.542
RUGGEDNESS
The Ruggedness of an analytical method is degree of reproducibility of 
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test  result  obtained by the  analysis  of  the  same sample  under  a  variety   of 
normal test condition, such as different laboratories, different analyst, different 
instruments, different lots of reagents, different elapsed assay times, different 
assay temperature, different days, etc.
Ruggedness is normally expressed as the lack of influence on test result 
of operational and environmental variables of the analytical method.
Determination:
The ruggedness of an analytical method was determined by analysis of 
aliquots  from homogeneous  lots  by  different  analysts  using  operational  and 
environmental  conditions that  may differ  but  were still  with in the specified 
parameters of the assay.  The degree of reproducibility of test result was then 
determined  as  a  function  of  the  assay  variables.   This  reproducibility  was 
assayed  under  normal  conditions  to  obtain  a  measure  of  the  ruggedness  of 
analytical method.
The  assay  of  DIACEREIN  and  ACECLOFENAC  were  performed  in 
different conditions like different analyst on different days.
Method:
The  standard and sample  solutions were prepared by different analysts 
107
on different days and the resulting solution were injected and chromatograms 
are recorded and  shown in following graphs and ruggedness of the  method and 
report of Diacerein and Aceclofenac are shown in Table 22.
                                                       Table-22
RUGGEDNESS
Analyst
Date
Amount Found %purity
Diacerein
   mg
Aceclofenac
    mg
Diacerein Aceclofenac
I 05.11.2008 50.17 100.05 100.34 100.05
II 06.11.2008 49.99 100.72 99.98 100.72
ROBUSTNESS
Robustness of an analytical method is measure of its capacity to remain 
unaffected by small but deliberate variations in method parameters and provides 
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an indication of its reliability during normal usage.
Determination:
The robustness of an analytical method was determined by analysis of 
aliquots from homogenous lots by differing physical parameters that may differ 
but were still within the specified parameter of the assay for example change in 
physical parameters like flow rate and lambda max.
Method:
Standard solution preparation:
100.2mg of Diacerin and 200.2mg Aceclofenac was transferred into a 
100ml dried volumetric flask.  The compounds were first dissolved in 10ml of 
THF.Then the volume was adjusted to 100ml with mobile phase.  From the 
stock solution 5ml was transferred to a 50ml volumetric flask and the volume 
was adjusted to 50ml with mobile phase to get a concentration of 50µg/ml of 
Diacerin and 100µg/ml of Aceclofenac. 
Sample preparation:
Twenty  tablets  were  weighed  and  powdered.   512.6mg  sample  tablet 
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DYCERIN-A(equivalent  to  100.1mg  of  Aceclofenac  and  50.1mg  Diacerein) 
was taken into 100ml dried volumetric flask.  The powder was first dissolved in 
10ml of THF and sonicated and finally the volume was adjusted to 100ml with 
mobile phase.  From this solution 5ml was transferred to 50ml volumetric flask 
and volume was adjusted to 50ml with mobile phase to get a concentration of 
100µg/ml of Aceclofenac and 50µg/ml of Diacerein. 20µl of the solution was 
injected and the chromatogram obtained is shown in following graphs.
                                The amount of Aceclofenac and Diacerein present in the 
tablet formulation was calculated by comparing the peak area of the standard 
and reports are given in Table-23-30
Table 23
Chromatographic condition:- change in flow rate (2 - 0.2ml/min)
110
Change in flow rate  1.8ml/min
Column C18
Wave length 265nm
Temperature Ambient25oc
Injection Volume 20µl
Table 24
Change in flow rate (1.8 ml/min)
S.No. Drug Average
Standard Area
Average
Sample 
Area
% Purity w/
v
1. Diacerein 6542.189 6585.098 100.3
2. Aceclofena
c
4952.103 4974.121 100.12
Table 25
Chromatographic condition:- change in flow rate (2+0.2ml/min)
Change in flow rate 2.2 ml/min
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Column C18
Wave length 265nm
Temperature Ambient25oc
Injection Volume 20µl
Table 26
Change in flow rate (2.2 ml/min)
S.No. Drug Average
Standard Area
Average
Sample 
Area
% Purity w/
v
1. Diacerein 4747.625 4770.182 100.12
2. Aceclofena
c
          3838.522 3850.198 99.98
Table 27
Chromatographic condition:- change in Lambda max 263 nm
 flow rate 2.0 ml/min
Column C18
Wave length 263nm
Temperature Ambient25oc
Injection Volume 20µl
Table 28
Change in Lambda max 263 nm
S.No. Drug Average
Standard Area
Average
Sample 
Area
% Purity w/
v
1. Diacerein 5581.541 5596.858 99.92
2. Aceclofena
c
          4201.808 4258.008 101.01
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Table 29
Chromatographic condition:- change in Lambda max 267 nm
 flow rate 2.0 ml/min
Column C18
Wave length 267nm
Temperature Ambient25oc
Injection Volume 20µl
Table 30
Change in Lambda max 267 nm
S.No. Drug Average
Standard Area
Average
Sample 
Area
% Purity w/
v
1. Diacerein 5317.509 5357.509 100.4
2. Aceclofena
c
           4106.019 4152.287 100.8
SYSTEM SUITABILITY PARAMETERS
System  suitability  testing  is  an  integral  part  of  many  analytical 
procedures.  The test is based on the concept that the equipment, electronics, 
analytical operation and sample to be analysed constitute an integral system that 
can be evaluated as such.  System suitability test parameters to be established 
for  a particular procedure depend on the type of procedure being validated.
Method:
A solution  of   100.1  µg/ml  Diacerein   and  Aceclofenac  200.2  µg/ml 
were prepared by diluting with  mobile phase and same was injected and a 
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chromatogram was recorded and they are shown in the following graph and 
system suitability report are shown in the following Table-31
Table 31
System suitability parameters
S.No. Parameters Diacerein Aceclofenac
1. Theoretical plates 3830 6722
2. Tailing factor 1.263 0.917
3. Resolution 9.948
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RESULTS AND DISCUSSION
Aceclofenac and Diacerein
UV  spectrophotometry  by  simultaneous  equation  method  and  reverse 
phase high performance liquid chromatography were developed for analysing 
Aceclofenac and Diacerein in combined tablet dosage form.
For  UV spectrophotometry linearity  was obtained in the concentration 
range of 5 to 50 μg/ml for Aceclofenac and 5 to 50 μg/ml for Diacerein. In 
quantitative  determination  the  Percentage  Drug  content  was  found  to  be 
100.11% and 100.10% for Aceclofenac and Diacerein respectively. Recovery 
experiments  were  performed and it  was  within  98  –  102% ,  the percentage 
relative standard deviation were found to be <2% which shows high precision 
and accuracy of the method.
In HPLC method, HPLC conditions were optimized to obtain an adequate 
separation of eluted compounds. Initially various mobile phase were tried, to 
separate  drugs.  Mobile  phase  and  flow  rate  selection  was  based  on  peak 
parameters  (height,  tailing,  theoretical  plates,  etc).  The  system  with  buffer 
(Potassium  di  hydrogen  ortho  phosphate  pH  3):  Acetonitrile  :  methanol 
(45:35:20 v/v) with 2 ml/min flow rate is quite robust. The optimum wavelength 
for  detection  was  265nm  at  which  better  detector  response  for  drugs  was 
obtained.  The  average  retention  times  for  3.52  minutes  for  Diacerein  ,6.2 
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minutes  for Aceclofenac respectively.
According  to  USP  system  suitability  test  are  an  integral  part  of 
chromatographic  method.  They  are  used  to  verify  the  reproducibility  of  the 
chromatographic system. To ascertain its effectiveness, system suitability tests 
were carried out on freshly prepared stock solution. Theoretical plates are found 
to be 3830 and 6722 for Diacerein and Aceclofenac respectively.
Tailing  factors  are  1.263  and  0.917  for  Diacerein  and  Aceclofenac 
respectively.The resolution between these drugs is 9.948.
The  calibration  curve  was  found  to  be  linear  for  both  Diacerein  & 
Aceclofenac.
The low values of Percentage RSD indicate the method is precise and 
accurate. The developed method was very specific without the interference of 
excipients.
The  percentage  purity  was  99.78%  and  100.29%  for  Diacerein  and 
Aceclofenac respectively.
The mean recoveries were found to be in the range of 98% to 102%.
Limit of detection for Diacerein and Aceclofenac was found to be 0.490 
μg/ml & 5.129 μg/ml respectively.
Limit  of  quantitation  for  Diacerein  and  Aceclofenac  was  found  to  be 
1.4855 μg/ml & 15.542 μg/ml respectively.
Robustness  of  the  proposed  method  was  determined  by  changing  the 
wavelength and flow rate.
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Ruggedness  of  proposed  method  was  determined by analysis  of 
aliquots  from homogenous  slot  by  different  analyst  in  different  days  using 
similar operational environmental condition. The results were within 98-102%.
Mosapride and Pantoprazole
UV  spectrophotometry  by  simultaneous  equation  method  and  reverse 
phase high performance liquid chromatography were developed for analysing 
Mosapride and Pantoprazole in combined dosage form.
For  UV spectrophotometry linearity  was obtained in the concentration 
range of 5 to 50 μg/ml for Aceclofenac and 5 to 50 μg/ml for Diacerein. In 
quantitative  determination  the  Percentage  Drug  content  was  found  to  be 
101.35% and 99.20% for Mosapride and Pantoprazole respectively. Recovery 
experiments  were  performed and it  was  within  98  –  102% ,  the percentage 
relative standard deviation were found to be <2% which shows high precision 
and accuracy of the method.
In HPLC method, HPLC conditions were optimized to obtain an adequate 
separation of eluted compounds. Initially various mobile phase were tried, to 
separate  drugs.  Mobile  phase  and  flow  rate  selection  was  based  on  peak 
parameters  (height,  tailing,  theoretical  plates,  etc).  The  system  with  buffer 
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(Glacial acetic acid pH 6): Acetonitrile : methanol (60:30:10 v/v) with 2 ml/min 
flow rate is quite robust. The optimum wavelength for detection was 278nm at 
which better detector response for drugs was obtained. The average retention 
times  for  6.13  minutes  for  Mosapride,2.65  minutes   for  Pantoprazole 
respectively.
According  to  USP  system  suitability  test  are  an  integral  part  of 
chromatographic  method.  They  are  used  to  verify  the  reproducibility  of  the 
chromatographic system. To ascertain its effectiveness, system suitability tests 
were  carried  out  on  freshly  prepared  stock  solution.Theoretical  plates  for 
Mosapride  and Pantoprazole  are  9699,5602 respectively.  Tailing  Factors  are 
found to be 1.789 and 1.184 for Mosapride,Pantoprazole respectively.
The Resolution between these two drurs was 17.841.
The  calibration  curve  was  found  to  be  linear  for  both  Mosapride  & 
Pantoprazole.
The low values of  Percentage RSD indicate the method is precise and 
accurate. The developed method was very specific without the interference of 
excipients.
The  percentage  purity  was  100.53% and  100.50% for  Mosapride  and 
Pantoprazole respectively.
The mean recoveries were found to be in the range of 98% to 102%.
Limit  of  detection  for  Mosapride  and  Pantoprazole  was  found  to  be 
0.00166 μg/ml & 0.0034 μg/ml respectively.
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Limit of quantitation for Mosapride and Pantoprazole was found to be 
0.00503 μg/ml & 0.0103 μg/ml respectively.
Robustness  of  the  proposed  method  was  determined  by  changing  the 
wavelength and flow rate.
Ruggedness  of  proposed  method  was  determined by analysis  of 
aliquots  from homogenous  slot  by  different  analyst  in  different  days  using 
similar operational environmental condition. The results were within 98-102%.
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 SUMMARY AND CONCLUSION            
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SUMMARY AND CONCLUSION
1. Aceclofenac  and Diacerein available  in  combined  dosage  form were 
analysed by UV–spectrophotometric simultaneous equation method and reverse 
phase high performance liquid chromatography.
On comparing both the methods reverse phase high performance liquid 
chromatography  was  found  to  be  more  accurate,  simple,  and  rapid  than 
simultaneous equation method.
           The values of standard deviation and relative standard deviation were 
found to be satisfactory.
2.     Mosapride and Pantoprazole available in combined dosage form were 
analysed by UV–spectrophotometric simultaneous equation method and reverse 
phase high performance liquid chromatography.
On comparing both the methods reverse phase high performance liquid 
chromatography  was  found  to  be  more  accurate,  simple,  and  rapid  than 
simultaneous equation method.
           The values of standard deviation and relative standard deviation were 
found to be satisfactory.
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